Finally, it has recently been suggested that glycine amidinotransferase (GATM), a gene that encodes the rate‐limiting enzyme in creatine synthesis, may be the functional link between statin‐mediated lowering of cholesterol and susceptibility to statin‐induced myopathy (Mangravite et al. The gene discussed is GATM; the disease is myopathy.